Year 1 Funding

We are tremendously grateful for the support and dedication of our Riders, Virtual Riders, Volunteers, Partners, and Donors.  The 2019 Paceline Ride raised $200k, which was granted to three areas of research at the Georgia Cancer Center.  Below are details of how those funds are helping cure cancer faster.

Major Equipment Award, Dr. Han-Fei Ding

Dr. Ding’s recommendation for the purchase of an Amersham ImageQuant 800 (IQ800) imager has been approved for funding for $50,000.  This imaging system provides high-resolution quantitative analyses for multiple sample types, and its highly sensitive detection capabilities automatically optimize the best signal-to-noise ratio when analyzing gels and blots.

Translational Research Award II, Dr. Huidong Shi and Dr. Ravindra Kolhe

Their project, “Cellular heterogeneity and tumor microenvironment in triple negative breast cancer disparities,” will receive up to $75,000 upon receipt and review of a full proposal.  Using single cell RNA sequencing technology, this research will address the disparity observed in triple negative breast cancer prevalence and treatment outcomes for African American versus Caucasian women.

Early Career Researcher Award, Dr. Zhi-Chun Ding

Dr. Ding’s project, “Targeting IFNg-induced CD4+ T Cell Exhaustion to Potentiate Cancer Immunotherapy,” was selected as the top-ranking proposal, to receive up to $75,000. Dr. Ding’s research aims to improve the efficacy of adoptive T-cell transfer (ACT) cancer therapeutic regimens, which rely on functional CD8+ and CD4+ T cells.  Using a novel model system, Dr. Ding will focus on overcoming one limitation of ACT: tumor-induced CD4+ T cell exhaustion.